Nonketotic hyperglycemic coma
Hyperosmolar diabetic coma (HNDC) is a rare, severe acute complication of diabetes, which is more common in elderly patients with no history of diabetes or mild non-insulin-dependent diabetes, but can also be seen in patients with insulin-dependent diabetes. The patient's original insulin secretion is insufficient, and the blood sugar rises rapidly under the influence of inducements, which promotes the aggravation of sugar metabolism disorders, causing the extracellular fluid to be hyperosmotic, hypovolemic hyperosmotic dehydration, and the original arteriosclerosis causing insufficient blood supply and hypoxia in the cerebral cortex, resulting in mental and neurological symptoms and coma.
-
Site of disease:
Brain Pancreas -
Infectious :
Not contagious -
Frequent population:
Elderly people, those with decreased renal function -
Related symptoms:
Polydipsia polyuria drowsiness thirst and polydipsia breath may smell like rotten apples -
Concurrent disease:
Related Drugs
Phenformin Hydrochloride Tablets
Indication: It is used for type 2 diabetes patients who are not satisfied with diet control alone, especially obese patients and patients with hyperinsulinemia. This product not only has the effect of lowering blood sugar, but also may help to reduce weight and hyperinsulinemia. For some diabetic patients who have poor response to sulfonylurea treatment, this product combined with sulfonylurea hypoglycemic drugs can produce a synergistic effect, which is better than the effect of using each alone.
Recombinant human insulin injection
Indication: Type 1 or type 2 diabetes.
Manufacturer:
Shenzhen Kexing Biotech Co., Ltd.
Rosiglitazone Maleate Tablets
Indication: This product is suitable for type 2 diabetes. Taking this product alone, supplemented with diet control and exercise, can control blood sugar in patients with type 2 diabetes. For patients with type 2 diabetes who have poor blood sugar control with diet control and exercise plus this product or with a single antidiabetic drug, this product can be used in combination with metformin or sulfonylurea drugs. For patients who take the maximum recommended dose of metformin or sulfonylurea drugs and have poor blood sugar control, if this product cannot replace the original antidiabetic drug, it needs to be used in combination with it. Dietary control is the first choice for the treatment of type 2 diabetes. Restricting calories, losing weight and increasing exercise can all help improve insulin sensitivity. Therefore, these measures are not only the basic treatment for type 2 diabetes, but also play an important role in effectively maintaining the efficacy of drugs. Before starting to take this product, diseases that affect blood sugar control, such as infection, should be diagnosed and treated.
Acarbose capsules
Indication: It can be used for insulin-dependent or non-insulin-dependent diabetes, and can also be used in combination with other oral hypoglycemic drugs or insulin.
Related Ingredients